SCHEMBL4311992

SCHEMBL4311992

COc1ccc(C)cc1C(O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.56
ALDH1A1 P00352 3/20 0.50
CYP3A4 P08684 1/20 0.50
ADRA2A P08913 2/20 0.44
ADRA1A P35348 2/20 0.44
CYP2D6 P10635 1/20 0.43
MEN1 O00255 2/20 0.42
MAPK1 P28482 2/20 0.42
KMT2A Q03164 2/20 0.42
BLM P54132 1/20 0.42
LPAR1 Q92633 4/20 0.41
GAA P10253 1/20 0.40
USP2 O75604 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
ALOX12 P18054 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12476289 0.86 ACHE (0.54) ACHEALDH1A1CYP3A4ADRA2AADRA1A
SCHEMBL14538804 0.83 ACHE (0.56) ACHEALDH1A1CYP3A4ADRA1AMEN1
SCHEMBL16240773 0.83 AMY1A (0.41) ACHEALDH1A1CYP3A4ADRA2AADRA1A
SCHEMBL6858946 0.82 CTSA (0.44) ACHEALDH1A1CYP3A4ADRA2AADRA1A
SCHEMBL17326806 0.81 ACHE (0.48) ACHEALDH1A1CYP3A4ADRA2AADRA1A
SCHEMBL29591727 0.81 ACHE (0.58) ACHEALDH1A1CYP3A4ADRA1ACYP2D6
SCHEMBL10238859 0.81 ACHE (0.58) ACHEALDH1A1CYP3A4ADRA1ACYP2D6
SCHEMBL14805541 0.80 ACHE (0.47) ACHEALDH1A1CYP3A4ADRA2AADRA1A
SCHEMBL5051458 0.80 ADRA2A (0.71) ACHEALDH1A1CYP3A4ADRA2AADRA1A
SCHEMBL7786327 0.80 ADRA2A (0.71) ACHEALDH1A1CYP3A4ADRA2AADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0212482-B1 PROCESS FOR OBTAINING NEGATIVE IMAGES FROM POSITIVE PHOTORESISTS HOECHST CELANESE CORPORATION (US) 1989-04-19 EP claimed
US-12572075-B2 Composition, method of forming resist underlayer film, and method of forming resist pattern JSR CORPORATION (JP) 2026-03-10 US disclosed
US-12265333-B2 Composition, resist underlayer film, method of forming resist underlayer film, method of producing patterned substrate, and compound JSR CORPORATION (JP) 2025-04-01 US disclosed
US-20240231231-A1 METHOD FOR FORMING RESIST UNDERLAYER FILM, METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE, COMPOSITION, AND RESIST UNDERLAYER FILM JSR CORPORATION (JP) 2024-07-11 US disclosed
US-20240030030-A1 METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE AND COMPOSITION JSR CORPORATION (JP) 2024-01-25 US disclosed
US-20240021429-A1 METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE AND COMPOSITION JSR CORPORATION (JP) 2024-01-18 US disclosed
EP-4270448-A1 FILM FORMATION METHOD AND ARTICLE MANUFACTURING METHOD CANON KABUSHIKI KAISHA (JP) 2023-11-01 EP disclosed
US-20230343591-A1 FILM FORMING METHOD AND ARTICLE MANUFACTURING METHOD CANON KABUSHIKI KAISHA (JP) 2023-10-26 US disclosed
WO-2023021971-A1 METHOD FOR FORMING RESIST UNDERLAYER FILM, METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE, COMPOSITION FOR FORMING RESIST UNDERLAYER FILM, AND RESIST UNDERLAYER FILM, JSR株式会社 2023-02-23 WO disclosed
US-20230041656-A1 COMPOSITION, METHOD OF FORMING RESIST UNDERLAYER FILM, AND METHOD OF FORMING RESIST PATTERN JSR CORPORATION (JP) 2023-02-09 US disclosed
US-20150198882-A9 COMPOSITION FOR FORMING RESIST UNDERLAYER FILM, RESIST UNDERLAYER FILM AND RESIST UNDERLAYER FILM-FORMING METHOD, AND PATTERN-FORMING METHOD JSR CORPORATION (JP) 2015-07-16 US disclosed
US-20140272722-A1 COMPOSITION FOR FORMING RESIST UNDERLAYER FILM, RESIST UNDERLAYER FILM AND RESIST UNDERLAYER FILM-FORMING METHOD, AND PATTERN-FORMING METHOD JSR CORPORATION (JP) 2014-09-18 US disclosed
US-8674043-B2 Photosensitive resin composition containing copolymer NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2014-03-18 US disclosed
US-8551453-B2 Aromatic triamide-lanthanide complexes THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-10-08 US disclosed
EP-2479612-A1 PHOTOSENSITIVE RESIN COMPOSITION CONTAINING COPOLYMER Nissan Chemical Industries, Ltd. (JP) 2012-07-25 EP disclosed
US-20120172557-A1 PHOTOSENSITIVE RESIN COMPOSITION CONTAINING COPOLYMER NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-07-05 US disclosed
US-20090036537-A1 AROMATIC TRIAMIDE-LANTHANIDE COMPLEXES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-02-05 US disclosed
EP-1706452-B1 AROMATIC TRIAMIDE-LANTHANIDE COMPLEXES UNIV CALIFORNIA OFFICE OF THE (US) 2008-09-03 EP disclosed
US-5306595-A A mixtures consists of water insoluble binder and ester condensation product of aromatic hydroxy and quinone diazides; solubility in solvents, storage stability HOECHST AKTIENGESELLSCHAFT (DE) 1994-04-26 US disclosed
US-5114816-A RADIATION-SENSITIVE COMPOUNDS, RADIATION-SENSITIVE MIXTURE PREPARED THEREWITH AND COPYING MATERIAL HOECHST AKTIENGESELLSCHAFT (DE) 1992-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12572075-B2 Composition, method of forming resist underlayer film, and method of forming resist pattern TOP1, NAF1, ASH2L ACHE 3866/4885ALDH1A1 2358/4885CYP3A4 2705/4885
US-20090036537-A1 AROMATIC TRIAMIDE-LANTHANIDE COMPLEXES TRPV5, TRPC5, TRPM5 ACHE 1881/4885ALDH1A1 3077/4885CYP3A4 3870/4885
US-12265333-B2 Composition, resist underlayer film, method of forming resist underlayer film, method of producing patterned substrate, and compound TOP1, RER1, ABCC1 ACHE 1882/4885ALDH1A1 2120/4885CYP3A4 810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.